UROLOGY

Expectant Management of Localized Prostate Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Expectant Management of Localized Prostate Cancer

© Springer-Verlag London 2015Vinod H. Nargund, Derek Raghavan and Howard M. Sandler (eds.)Urological Oncology10.1007/978-0-85729-482-1_41 41. Expectant Management of Localized Prostate Cancer Maria Carmen Mir1 and Andrew J. Stephenson2   (1) Department of Urology, Cleveland Clinic, Cleveland, OH, USA (2) Glickman Urological…

read more

Principles of Radiotherapy in Urologic Tumors

Jul 4, 2016 by in UROLOGY Comments Off on Principles of Radiotherapy in Urologic Tumors

The BED normally carries a subscript corresponding to the assumed α/β since it is clearly different for large and small α/β. Thus, for any given fractionation schedule, one must determine…

read more

Genetics and Genito-Urinary Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Genetics and Genito-Urinary Cancer

Fig. 3.1 Clonal evolution drives tumor progression. (a) Healthy epithelium. (b) The first oncogenic mutation occurs in a single epithelium cell (Yellow cell) resulting in the growth of a genetically…

read more

Surgical Management of Bladder Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Surgical Management of Bladder Cancer

1. Muscle invasive (≥T2) bladder cancer 2. Select patients with recurrent high grade T1 or CIS 3. BCG and intravesical chemotherapy failures: high grade T1, with concomitant CIS, multifocal disease…

read more

Invasive Bladder Cancer: Combined Modality Treatment

Jul 4, 2016 by in UROLOGY Comments Off on Invasive Bladder Cancer: Combined Modality Treatment

Parameter Limitation Examples Laboratory methodology New assay system Standardization in progress What is “normal”? Optimal technology?  e.g. I-H vs. FISH?  e.g. RNA vs. protein?  Inter-laboratory variation Lab test applied to…

read more

Intravesical Therapy for Bladder Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Intravesical Therapy for Bladder Cancer

57. Herr HW, Dalbagni G. Defining bacillus Calmette-Guerin refractory superficial bladder tumors. J Urol. 2003;169(5):1706–8.PubMed 58. Solsona E, Iborra I, Dumont R, et al. The 3-month clinical response to intravesical…

read more

Chemotherapy for Testicular Cancer

Jul 4, 2016 by in UROLOGY Comments Off on Chemotherapy for Testicular Cancer

Variable 0 1 2 3 Primary site Gonadal Retroperitoneal  Mediastinal Response 1st line CR/PRm- PRm+/SD PD  PFI >3 months ≤3 months   AFP at salvage normal <1,000 >1,000   LBB at salvage…

read more
Get Clinical Tree app for offline access